Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Novel immunomodulatory therapies in myasthenia gravis].
Sukockiené E, Théaudin M, Loser V, Staedler K, Lalive PH, Lascano AM. Sukockiené E, et al. Among authors: lalive ph. Rev Med Suisse. 2024 Apr 24;20(871):848-851. doi: 10.53738/REVMED.2024.20.871.848. Rev Med Suisse. 2024. PMID: 38665106 Review. French.
Syndrome de Guillain-Barré.
Nemitz I, Lascano AM, Lalive PH, Plan PA. Nemitz I, et al. Among authors: lalive ph. Rev Med Suisse. 2018 Apr 11;14(602):807-809. Rev Med Suisse. 2018. PMID: 29658222 French. No abstract available.
Update in immunosuppressive therapy of myasthenia gravis.
Lascano AM, Lalive PH. Lascano AM, et al. Among authors: lalive ph. Autoimmun Rev. 2021 Jan;20(1):102712. doi: 10.1016/j.autrev.2020.102712. Epub 2020 Nov 13. Autoimmun Rev. 2021. PMID: 33197578 Free article. Review.
[Anti-MOG associated disease].
Lerusse J, Uginet M, Théaudin M, Bernard-Valnet R, Pot C, Lalive PH. Lerusse J, et al. Among authors: lalive ph. Rev Med Suisse. 2024 Apr 24;20(871):828-832. doi: 10.53738/REVMED.2024.20.871.828. Rev Med Suisse. 2024. PMID: 38665102 French.
[Discontinuing disease-modifying therapies in multiple sclerosis].
Bernard-Valnet R, Lalive PH, Bréville G, Théaudin M, Pot C, Du Pasquier R. Bernard-Valnet R, et al. Among authors: lalive ph. Rev Med Suisse. 2024 Apr 24;20(871):843-847. doi: 10.53738/REVMED.2024.20.871.843. Rev Med Suisse. 2024. PMID: 38665105 French.
[Myasthenia gravis: treatments and remissions].
Dunand M, Lalive PH, Vokatch N, Kuntzer T. Dunand M, et al. Among authors: lalive ph. Rev Med Suisse. 2007 May 9;3(110):1185-6, 1188-90. Rev Med Suisse. 2007. PMID: 17564346 Review. French.
[Treatments for multiple sclerosis: update].
Uginet M, Lefeuvre L, Lerusse J, Pot C, Du Pasquier R, Lalive PH. Uginet M, et al. Among authors: lalive ph. Rev Med Suisse. 2024 Apr 24;20(871):837-842. doi: 10.53738/REVMED.2024.20.871.837. Rev Med Suisse. 2024. PMID: 38665104 Review. French.
173 results